Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA CIPLA AUROBINDO PHARMA/
CIPLA
 
P/E (TTM) x 23.0 32.2 71.3% View Chart
P/BV x 2.4 5.2 46.0% View Chart
Dividend Yield % 0.3 0.6 48.4%  

Financials

 AUROBINDO PHARMA   CIPLA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
CIPLA
Mar-23
AUROBINDO PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs7151,185 60.3%   
Low Rs397852 46.6%   
Sales per share (Unadj.) Rs424.2281.9 150.5%  
Earnings per share (Unadj.) Rs32.935.1 93.6%  
Cash flow per share (Unadj.) Rs54.149.7 109.0%  
Dividends per share (Unadj.) Rs3.008.50 35.3%  
Avg Dividend yield %0.50.8 64.7%  
Book value per share (Unadj.) Rs458.1289.2 158.4%  
Shares outstanding (eoy) m585.94807.15 72.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.33.6 36.3%   
Avg P/E ratio x16.929.0 58.3%  
P/CF ratio (eoy) x10.320.5 50.1%  
Price / Book Value ratio x1.23.5 34.5%  
Dividend payout %9.124.2 37.7%   
Avg Mkt Cap Rs m325,753822,164 39.6%   
No. of employees `000NANA-   
Total wages/salary Rs m35,22338,301 92.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,554227,531 109.2%  
Other income Rs m2,9065,121 56.7%   
Total revenues Rs m251,460232,653 108.1%   
Gross profit Rs m37,07048,079 77.1%  
Depreciation Rs m12,44611,721 106.2%   
Interest Rs m1,4051,095 128.2%   
Profit before tax Rs m26,12540,384 64.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,84912,029 56.9%   
Profit after tax Rs m19,27728,355 68.0%  
Gross profit margin %14.921.1 70.6%  
Effective tax rate %26.229.8 88.0%   
Net profit margin %7.812.5 62.2%  
BALANCE SHEET DATA
Current assets Rs m214,599168,051 127.7%   
Current liabilities Rs m114,93850,333 228.4%   
Net working cap to sales %40.151.7 77.5%  
Current ratio x1.93.3 55.9%  
Inventory Days Days2173 28.1%  
Debtors Days Days667 1,007.8%  
Net fixed assets Rs m176,668117,318 150.6%   
Share capital Rs m5861,614 36.3%   
"Free" reserves Rs m267,813231,845 115.5%   
Net worth Rs m268,399233,460 115.0%   
Long term debt Rs m6,1900-   
Total assets Rs m392,125290,067 135.2%  
Interest coverage x19.637.9 51.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.8 80.8%   
Return on assets %5.310.2 51.9%  
Return on equity %7.212.1 59.1%  
Return on capital %10.017.8 56.4%  
Exports to sales %33.722.6 148.7%   
Imports to sales %15.38.9 172.5%   
Exports (fob) Rs m83,70351,516 162.5%   
Imports (cif) Rs m38,06020,202 188.4%   
Fx inflow Rs m85,48364,282 133.0%   
Fx outflow Rs m41,44720,202 205.2%   
Net fx Rs m44,03644,080 99.9%   
CASH FLOW
From Operations Rs m23,86832,377 73.7%  
From Investments Rs m-39,778-23,885 166.5%  
From Financial Activity Rs m18,144-9,583 -189.3%  
Net Cashflow Rs m2,298-968 -237.4%  

Share Holding

Indian Promoters % 48.8 13.4 363.1%  
Foreign collaborators % 3.1 20.0 15.3%  
Indian inst/Mut Fund % 41.3 50.0 82.7%  
FIIs % 20.7 25.7 80.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 66.5 72.4%  
Shareholders   241,944 425,731 56.8%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Aurobindo Pharma vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Cipla Share Price Performance

Period Aurobindo Pharma Cipla S&P BSE HEALTHCARE
1-Day 1.82% 1.94% 1.18%
1-Month 5.96% 1.25% -0.75%
1-Year 113.07% 68.02% 61.82%
3-Year CAGR 7.78% 22.53% 18.16%
5-Year CAGR 7.18% 23.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.